CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C13004 | BRD-K33350866 | BRD-K33350866 | -- | -- | -- | Details |
| C13005 | BRD-K33368320 | BRD-K33368320 | -- | -- | -- | Details |
| C13006 | BRD-K33368990 | BRD-K33368990 | -- | -- | -- | Details |
| C13007 | BRD-K33371292 | BRD-K33371292 | -- | -- | -- | Details |
| C13008 | BRD-K33379087 | tivantinib | MET | Tyrosine kinase inhibitor | -- | Details |
| C13009 | BRD-K33379484 | BRD-K33379484 | -- | -- | -- | Details |
| C13010 | BRD-K33380066 | BRD-K33380066 | -- | -- | -- | Details |
| C13011 | BRD-K33384411 | SA-419021 | -- | -- | -- | Details |
| C13012 | BRD-K33385950 | BRD-K33385950 | -- | -- | -- | Details |
| C13013 | BRD-K33390612 | BRD-K33390612 | -- | -- | -- | Details |
| C13014 | BRD-K33392208 | BRD-K33392208 | -- | -- | -- | Details |
| C13015 | BRD-K33394674 | BRD-K33394674 | -- | -- | -- | Details |
| C13016 | BRD-K33396764 | BRD-K33396764 | -- | -- | alpha-linolenic-acid | Details |
| C13017 | BRD-K33400588 | BRD-K33400588 | -- | -- | -- | Details |
| C13018 | BRD-K33407589 | BRD-K33407589 | -- | -- | -- | Details |
| C13019 | BRD-K33420995 | BRD-K33420995 | -- | -- | -- | Details |
| C13020 | BRD-K33422401 | PMSF | -- | -- | pmsf | Details |
| C13021 | BRD-K33425534 | exemestane | CYP19A1 | Aromatase inhibitor | -- | Details |
| C13022 | BRD-K33438042 | BRD-K33438042 | -- | -- | -- | Details |
| C13023 | BRD-K33445737 | BRD-K33445737 | -- | -- | -- | Details |
| C13024 | BRD-K33448511 | BRD-K33448511 | -- | -- | -- | Details |
| C13025 | BRD-K33449128 | BRD-K33449128 | -- | -- | -- | Details |
| C13026 | BRD-K33451389 | BRD-K33451389 | -- | -- | -- | Details |
| C13027 | BRD-K33452357 | BRD-K33452357 | -- | -- | -- | Details |
| C13028 | BRD-K33453127 | BRD-K33453127 | -- | -- | -- | Details |
| C13029 | BRD-K33453211 | levocabastine | NTSR2; HRH1 | Histamine receptor antagonist | -- | Details |
| C13030 | BRD-K33454318 | BRD-K33454318 | -- | -- | -- | Details |
| C13031 | BRD-K33454337 | BRD-K33454337 | -- | -- | -- | Details |
| C13032 | BRD-K33456231 | BRD-K33456231 | -- | -- | -- | Details |
| C13033 | BRD-K33459542 | ditolylguanidine | -- | -- | -- | Details |
| C13034 | BRD-K33459729 | BRD-K33459729 | -- | -- | -- | Details |
| C13035 | BRD-K33461572 | BRD-K33461572 | -- | -- | -- | Details |
| C13036 | BRD-K33462260 | BRD-K33462260 | -- | -- | -- | Details |
| C13037 | BRD-K33462580 | BRD-K33462580 | -- | -- | -- | Details |
| C13038 | BRD-K33475837 | BRD-K33475837 | -- | -- | -- | Details |
| C13039 | BRD-K33480200 | BRD-K33480200 | -- | -- | -- | Details |
| C13040 | BRD-K33483445 | BRD-K33483445 | -- | -- | -- | Details |
| C13041 | BRD-K33483813 | actarit | -- | -- | -- | Details |
| C13042 | BRD-K33486590 | BRD-K33486590 | -- | -- | -- | Details |
| C13043 | BRD-K33490627 | BRD-K33490627 | -- | -- | -- | Details |
| C13044 | BRD-K33493537 | BRD-K33493537 | -- | -- | -- | Details |
| C13045 | BRD-K33495169 | KUC104235N | -- | -- | KUC-104235N | Details |
| C13046 | BRD-K33495825 | BRD-K33495825 | -- | -- | -- | Details |
| C13047 | BRD-K33497830 | BRD-K33497830 | -- | -- | -- | Details |
| C13048 | BRD-K33503286 | BRD-K33503286 | -- | -- | -- | Details |
| C13049 | BRD-K33504592 | BRD-K33504592 | -- | -- | -- | Details |
| C13050 | BRD-K33505770 | BRD-K33505770 | -- | -- | -- | Details |
| C13051 | BRD-K33510044 | BRD-K33510044 | -- | -- | -- | Details |
| C13052 | BRD-K33514849 | BRD-K33514849 | -- | -- | -- | Details |
| C13053 | BRD-K33518436 | BRD-K33518436 | -- | -- | -- | Details |
| C13054 | BRD-K33528640 | BRD-K33528640 | -- | -- | -- | Details |
| C13055 | BRD-K33530763 | BRD-K33530763 | -- | -- | -- | Details |
| C13056 | BRD-K33537450 | BRD-K33537450 | -- | -- | -- | Details |
| C13057 | BRD-K33539506 | BRD-K33539506 | -- | -- | 3-[4-(4-methylphenyl)-1,3-thiazol-2-yl]-1H-indole | Details |
| C13058 | BRD-K33544525 | BRD-K33544525 | -- | -- | -- | Details |
| C13059 | BRD-K33551950 | radicicol | -- | -- | -- | Details |
| C13060 | BRD-K33562246 | BRD-K33562246 | -- | -- | -- | Details |
| C13061 | BRD-K33563922 | BRD-K33563922 | -- | -- | -- | Details |
| C13062 | BRD-K33572481 | taurodeoxycholic-acid | -- | -- | -- | Details |
| C13063 | BRD-K33573676 | BRD-K33573676 | -- | -- | -- | Details |
| C13064 | BRD-K33575007 | BRD-K33575007 | -- | -- | -- | Details |
| C13065 | BRD-K33576455 | BRD-K33576455 | -- | -- | -- | Details |
| C13066 | BRD-K33583600 | BRD-K33583600 | -- | -- | isoliquiritigenin | Details |
| C13067 | BRD-K33586157 | BRD-K33586157 | -- | -- | -- | Details |
| C13068 | BRD-K33586289 | EPZ-020411 | -- | -- | -- | Details |
| C13069 | BRD-K33591392 | BRD-K33591392 | -- | -- | -- | Details |
| C13070 | BRD-K33593585 | BRD-K33593585 | -- | -- | -- | Details |
| C13071 | BRD-K33597325 | BRD-K33597325 | -- | -- | -- | Details |
| C13072 | BRD-K33597548 | BRD-K33597548 | -- | -- | -- | Details |
| C13073 | BRD-K33603918 | BRD-K33603918 | -- | -- | -- | Details |
| C13074 | BRD-K33606137 | BRD-K33606137 | -- | -- | -- | Details |
| C13075 | BRD-K33606495 | BRD-K33606495 | -- | -- | -- | Details |
| C13076 | BRD-K33606963 | BRD-K33606963 | -- | -- | -- | Details |
| C13077 | BRD-K33610132 | rociletinib | EGFR | EGFR inhibitor | -- | Details |
| C13078 | BRD-K33610498 | BRD-K33610498 | -- | -- | -- | Details |
| C13079 | BRD-K33616265 | BRD-K33616265 | -- | -- | -- | Details |
| C13080 | BRD-K33619512 | BRD-K33619512 | -- | -- | -- | Details |
| C13081 | BRD-K33620583 | BRD-K33620583 | -- | -- | -- | Details |
| C13082 | BRD-K33622447 | LY-2835219 | -- | -- | -- | Details |
| C13083 | BRD-K33631051 | BRD-K33631051 | -- | -- | -- | Details |
| C13084 | BRD-K33635485 | BRD-K33635485 | -- | -- | -- | Details |
| C13085 | BRD-K33637182 | BRD-K33637182 | -- | -- | -- | Details |
| C13086 | BRD-K33637419 | BRD-K33637419 | -- | -- | -- | Details |
| C13087 | BRD-K33640715 | BRD-K33640715 | -- | -- | -- | Details |
| C13088 | BRD-K33653343 | BRD-K33653343 | -- | -- | -- | Details |
| C13089 | BRD-K33666425 | BRD-K33666425 | -- | -- | -- | Details |
| C13090 | BRD-K33668351 | BRD-K33668351 | -- | -- | -- | Details |
| C13091 | BRD-K33668505 | BRD-K33668505 | -- | -- | -- | Details |
| C13092 | BRD-K33676730 | BRD-K33676730 | -- | -- | -- | Details |
| C13093 | BRD-K33680967 | BRD-K33680967 | -- | -- | -- | Details |
| C13094 | BRD-K33685212 | BRD-K33685212 | -- | -- | -- | Details |
| C13095 | BRD-K33689388 | BRD-K33689388 | -- | -- | -- | Details |
| C13096 | BRD-K33689641 | BRD-K33689641 | -- | -- | -- | Details |
| C13097 | BRD-K33690734 | 5-BDBD | P2RX4 | Purinergic receptor antagonist | -- | Details |
| C13098 | BRD-K33693037 | BRD-K33693037 | -- | -- | -- | Details |
| C13099 | BRD-K33697018 | BRD-K33697018 | -- | -- | -- | Details |
| C13100 | BRD-K33702515 | BRD-K33702515 | -- | -- | -- | Details |
| C13101 | BRD-K33705415 | BRD-K33705415 | -- | -- | -- | Details |
| C13102 | BRD-K33710385 | BRD-K33710385 | -- | -- | -- | Details |
| C13103 | BRD-K33711030 | BRD-K33711030 | -- | -- | -- | Details |